Definitive radiochemotherapy of advanced head and neck cancer with carboplatin and paclitaxel: A phase II study

Strahlentherapie und Onkologie

Volumn 187, Issue 10, 2011, Pages 645-650

  Semrau, Robert ^a   Temming, Susanne ^a   Preuss, Simon Florian ^b   Klumann, Jens Peter ^c   Guntinas Lichius, Orlando ^d   Müller, Rolf Peter ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Chemotherapy; Head and neck cancer; Radiotherapy; Taxanes

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ACUTE TOXICITY; ADULT; ADVANCED CANCER; AGED; ALLERGIC REACTION; ANEMIA; AREA UNDER THE CURVE; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; DERMATITIS; DRUG EFFECT; DRUG WITHDRAWAL; FEEDING APPARATUS; FEMALE; FOLLOW UP; HUMAN; HYPOPHARYNX CANCER; HYPOPHARYNX CARCINOMA; IMPLANTATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; OROPHARYNX CANCER; OROPHARYNX CARCINOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; SQUAMOUS CELL CARCINOMA; SURVIVAL; THROMBOCYTOPENIA; WORLD HEALTH ORGANIZATION; XEROSTOMIA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; ENTERAL NUTRITION; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LEUKOPENIA; MALE; MIDDLE AGED; MUCOSITIS; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PACLITAXEL; RADIATION INJURIES; RADIOTHERAPY DOSAGE; THROMBOCYTOPENIA;

EID: 80755171191     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-011-1111-7     Document Type: Article

References (29)

1. A. Abitbol M. Abdel-Wahab A. Lewin 2002 Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head- and-neck squamous cell carcinoma: A-2 protocol Int J Radiat Oncol Biol Phys 53 942 7 12095561 10.1016/S0360-3016(02)02816-X 1:CAS:528:DC%2BD38XkvFyrtrw%3D (Pubitemid 34722640)
2. S.S. Agarwala E. Cano D.E. Heron 2007 Long-term outcomes with concurrent carboplatin, paclitaxel and radiation therapy for locally advanced, inoperable head and neck cancer Ann Oncol 18 1224 9 17675395 10.1093/annonc/mdm088 1:STN:280:DC%2BD2srovVyqtQ%3D%3D (Pubitemid 47244370)
3. P. Balermpas M. Hambek O. Seitz 2009 Combined cetuximab and reirradiation for locoregional recurrent and inoperable squamous cell carcinoma of the head and neck Strahlenther Onkol 185 775 81 20013086 10.1007/s00066-009-2092-7
4. V. Budach M. Stuschke W. Budach 2005 Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial J Clin Oncol 23 1125 35 15718308 10.1200/JCO.2005.07.010 1:CAS:528:DC%2BD2MXitl2gtbY%3D (Pubitemid 46202268)
5. A.K. Chan P. Sanghera B.A. Choo 2011 Hypofractionated accelerated radiotherapy with concurrent carboplatin for locally advanced squamous cell carcinoma of the head and neck Clinical Oncology 23 34 9 20863676 10.1016/j.clon.2010.07.015 1:STN:280:DC%2BC3M%2Fms12qsw%3D%3D
6. P.B. Chougule M.S. Akhtar R. Rathore 2008 Concurrent chemoradiotherapy with weekly paclitaxel and carboplatin for locally advanced head and neck cancer: long-term follow-up of a Brown University Oncology Group Phase II Study (HN-53) Head Neck 30 289 96 17657799 10.1002/hed.20700 (Pubitemid 351480743)
7. D. Citrin J. Mansueti A. Likhacheva 2009 Long-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced head-and-neck cancer Int J Radiat Oncol Biol Phys 74 4 1040 6 19117692 10.1016/j.ijrobp.2008. 09.053
8. A.J. Cmelak B.A. Murphy B. Burkey 2007 Taxane-based chemoirradiation for organ preservation with locally advanced head and neck cancer: results of a phase II multi-institutional trial Head Neck 29 315 24 17252600 10.1002/hed.20522 (Pubitemid 46623496)
9. A. Eisbruch J. Harris A.S. Garden 2010 Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22) Int Journal Radiat Oncol Biol Phys 76 1333 8 10.1016/j.ijrobp.2009.04.011
10. A. Ernst-Stecken G. Grabenbauer H. Iro 2004 Phase II trial of hyperfractionated accelerated split-course radiochemotherapy with 5-FU and cis-DDP in advanced head and neck cancer Strahlenther Onkol 180 805 10 15592701 10.1007/s00066-004-1307-1 (Pubitemid 40100830)
11. O. Feher S.J. Martins C.A. Lima 2002 Pilot trial of concomitant chemotherapy with paclitaxel and split-course radiotherapy for very advanced squamous cell carcinoma of head and neck Head Neck 24 228 35 11891954 10.1002/hed.10049 (Pubitemid 34193247)
12. V. Gregoire A. Eisbruch M. Hamoir 2006 Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck Radiother Oncol 79 15 20 16616387 10.1016/j.radonc.2006.03.009
13. R. Haddad S. Sonis M. Posner 2009 Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer Cancer 115 4514 23 19634161 10.1002/cncr.24525 1:CAS:528:DC%2BD1MXht1Kit7bF
14. Halim AA, Wahba HA, El-Hadaad HA et al. Concomitant chemoradiotherapy using low-dose weekly gemcitabine versus low-dose weekly paclitaxel in locally advanced head and neck squamous cell carcinoma: a phase III study. Med Oncol 2011. DOI: 10.1007/s12032-010-9811-x.
15. T. Kuhnt A. Becker S. Pigorsch 2003 Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial Strahlenther Onkol 179 673 81 14566475 10.1007/s00066-003-1106-0 (Pubitemid 37254661)
16. M. Machtay V. Aviles M.M. Kligerman 1999 A phase I trial of 96-hour paclitaxel infusion plus accelerated radiotherapy of unrespectable head and neck cancer Int J Radiat Oncol Biol Phys 44 311 5 10760424 10.1016/S0360-3016(99) 00027-9 1:CAS:528:DyaK1MXjtVWqtr8%3D (Pubitemid 29205027)
17. J.P. Pignon A. le Maitre E. Maillard 2009 Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients Radiother Oncol 92 4 14 19446902 10.1016/j.radonc.2009.04.014
18. S.F. Preuss V. Dinh J.P. Klussmann 2007 Outcome of multimodal treatment for oropharyngeal carcinoma: a single institution experience Oral Oncology 43 402 7 17071133 10.1016/j.oraloncology.2006.04.015 (Pubitemid 46413987)
19. G. Sanguinetti P. Adapala E.J. Endres 2007 Dosimetric predictors of laryngeal edema Int J Radiat Oncology Biol Phys 8 741 9 10.1016/j.ijrobp.2007. 01.010 (Pubitemid 46818739)
20. E. Selzer S. Liederer C. Lemaire 2011 Incidence of dermatitis in head and neck cancer patients treated with primary radiotherapy and cetuximab Strahlenther Onkol 187 373 7 21603990 10.1007/s00066-011-2217-7
21. R. Semrau R.P. Mueller H. Stuetzer 2006 Efficacy of intensified hyperfractionated and accelerated radiotherapy and concurrent chemotherapy with carboplatin and 5-fluorouracil: updated results of a randomized multicentric trial in advanced head-and-neck cancer Int J Radiat Oncol Biol Phys 64 1308 16 16464538 10.1016/j.ijrobp.2005.10.039 1:CAS:528:DC%2BD28XjtFWqtrw%3D
22. S. Semrau F. Waldfahrer M. Lell 2011 Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradiotherapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. Early results Strahlenther Onkol 187 15 22 21234526 10.1007/s00066-010-2178-2
23. D. Steinmann B. Cerny J. Karstens 2009 Chemoradiotherapy with weekly cisplatin 40 mg/m2 in 103 head-and-neck cancer patients Strahlenther Onkol 185 682 8 19806334 10.1007/s00066-009-1989-5
24. J.B. Sunwoo L.L. Herscher G.S. Kroog 2001 Concurrent paclitaxel and radiation in the treatment of locally advanced head and neck cancer J Clin Oncol 19 800 11 11157034 1:CAS:528:DC%2BD3MXhtlGrt7o%3D (Pubitemid 32119096)
25. M. Suntharalingam M.L. Haas B.A. Conley 2000 The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck Int J Radiat Oncol Biol Phys 47 49 56 10758304 10.1016/S0360-3016(00)00408-9 1:CAS:528:DC%2BD3cXitlOrsro%3D (Pubitemid 30179676)
26. S. Tribius S. Kronemann Y. Kilic 2009 Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck Strahlenther Onkol 185 675 81 19806333 10.1007/s00066-009-1992-x
27. H.A. Wolff J. Bosch K. Jung 2010 High-grade acute organ toxicity as positive prognostic factor in primary radio(chemo)therapy for locally advanced, inoperable head and neck cancer Strahlenther Onkol 186 262 8 20437012 10.1007/s00066-010-2136-z
28. S.J. Wong P.M. Harari A.S. Garden 2011 Longitudinal oncology registry of head and neck carcinoma (LORHAN): analysis of chemoradiation treatment approaches in the United States Cancer 117 1679 86 21472715 10.1002/cncr.25721
29. F. Zwicker F. Roeder C. Thieke 2011 IMRT reirradiation with concurrent cetuximab immunotherapy in recurrent head and neck cancer Strahlenther Onkol 187 32 8 21234529 10.1007/s00066-010-2149-7